Correlation Between Neuropace and Cigna Corp
Can any of the company-specific risk be diversified away by investing in both Neuropace and Cigna Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Cigna Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Cigna Corp, you can compare the effects of market volatilities on Neuropace and Cigna Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Cigna Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Cigna Corp.
Diversification Opportunities for Neuropace and Cigna Corp
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neuropace and Cigna is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Cigna Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cigna Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Cigna Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cigna Corp has no effect on the direction of Neuropace i.e., Neuropace and Cigna Corp go up and down completely randomly.
Pair Corralation between Neuropace and Cigna Corp
Given the investment horizon of 90 days Neuropace is expected to generate 2.8 times more return on investment than Cigna Corp. However, Neuropace is 2.8 times more volatile than Cigna Corp. It trades about 0.05 of its potential returns per unit of risk. Cigna Corp is currently generating about 0.01 per unit of risk. If you would invest 875.00 in Neuropace on September 23, 2024 and sell it today you would earn a total of 278.00 from holding Neuropace or generate 31.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Cigna Corp
Performance |
Timeline |
Neuropace |
Cigna Corp |
Neuropace and Cigna Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Cigna Corp
The main advantage of trading using opposite Neuropace and Cigna Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Cigna Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cigna Corp will offset losses from the drop in Cigna Corp's long position.Neuropace vs. Cigna Corp | Neuropace vs. Definitive Healthcare Corp | Neuropace vs. Guardant Health | Neuropace vs. Laboratory of |
Cigna Corp vs. Definitive Healthcare Corp | Cigna Corp vs. Edwards Lifesciences Corp | Cigna Corp vs. Guardant Health | Cigna Corp vs. Laboratory of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |